Log in | Register

Acute kidney injury following acute liver failure: potential role of systemic cadmium mobilization?

Perrine Hoet| Vincent Haufroid| Gladys Deumer| Xavier Dumont| Dominique Lison| Philippe Hantson
Original
Volume 38, Issue 3 / March , 2012

Pages 467 - 473

Abstract

Objective

A significant fraction of patients with acute liver failure (ALF) suffer from a concomitant acute kidney injury (AKI), the mechanism of which is probably multifactorial. Cadmium (Cd) is a widespread environmental pollutant and a tubulotoxic metal that accumulates in the liver. We tested the hypothesis that a release of Cd during ALF may cause a redistribution of Cd from the liver to the kidneys and play a role in the occurrence of ALF-associated AKI.

Methods

Twenty patients with ALF (ALF-patients), 20 patients from the ICU with no liver damage at admission (ICU-controls) and 20 healthy controls were recruited to compare the 24-h urinary excretion rate of Cd with that of lead (Pb), a nephrotoxic metal that does not accumulate in the liver, and zinc (Zn), a non-nephrotoxic element found in high amounts in the liver. The excretion rates of the low-molecular-weight proteins (LMWPs) were monitored.

Results

ALF-patients excreted markedly more Cd than the healthy controls and ICU-controls. In ALF-patients, the four urinary LMWPs (RBP, β2-MG, CC16 and α1-MG) increased as a function of Cd excretion, with high correlation coefficients. The prevalence of patients excreting a high amount of LMWPs also increased with increasing Cd excretion. No relationship was found between the other elements investigated and the LMWPs, with the exception of copper, which shares close toxicokinetic similarities with Cd.

Conclusions

This study shows a strong association between urinary Cd levels and the excretion rates of LMWPs in patients with ALF. A causal relationship is possible but could not be fully demonstrated in this study.

Keywords

References

  1. McKinnell J, Holt S (2007) Liver disease and renal dysfunction. Medicine 35:521–523
    • View reference on publisher's website
  2. Moore K (1999) Renal failure in acute liver failure. Eur J Gastroenterol Hepatol 11:967–975
    • View reference on PubMed
    • View reference on publisher's website
  3. Eguia L, Materson BJ (1997) Acetaminophen-related acute renal failure without fulminant liver failure. Pharmacotherapy 17:363–370
    • View reference on PubMed
  4. Hengy B, Hayi-Slayman D, Page M, Christin F, Baillon JJ, Ber CE, Allaouchiche B, Rimmelé T (2009) Acute renal failure after acetaminophen poisoning: report of three cases. Can Anaesth 56:770–774
    • View reference on publisher's website
  5. Mazer M, Perrone J (2008) Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. J Med Toxicol 4:2–6
    • View reference on PubMed
    • View reference on publisher's website
  6. Wilkinson SP, Moodie H, Arroyo VA, Williams R (1977) Frequency of renal impairment in paracetamol overdose compared with other causes of acute liver damage. J Clin Pathol 30:141–143
    • View reference on PubMed
    • View reference on publisher's website
  7. Jarup L, Akesson A (2009) Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 238:201–208
    • View reference on PubMed
    • View reference on publisher's website
  8. U.S. Geological Survey (2009) U.S. Geological Survey mineral commodity summaries, January 2009. Available at: http://minerals.usgs.gov/minerals/pubs/commodity/cadmium/mcs-2009-cadmi.pdf. Accessed 1 Dec 2011
  9. European Chemicals Bureau (2007) European Union risk assessment report cadmium metal and cadmium oxide. Office for Official Publications of the European Communities, vol 74. EUR 22767 EN. European Union, Luxembourg
  10. Cain K, Griffiths B (1980) Transfer of liver cadmium to the kidney after aflatoxin induced liver damage. Biochem Pharmacol 29:1852–1855
    • View reference on PubMed
    • View reference on publisher's website
  11. Chan HM, Zhu LF, Zhong R, Grant D, Goyer RA, Cherian MG (1993) Nephrotoxicity in rats following liver transplantation from cadmium-exposed rats. Toxicol Appl Pharmacol 123:89–96
    • View reference on PubMed
    • View reference on publisher's website
  12. Bernard AM, Lauwerys RR (1981) The effects of sodium chromate and carbon tetrachloride on the urinary excretion and tissue distribution of cadmium in cadmium-pretreated rats. Toxicol Appl Pharmacol 57:30–38
    • View reference on PubMed
    • View reference on publisher's website
  13. Vanderperren B, Rizzo M, Angenot L, Haufroid V, Jadoul M, Hantson P (2005) Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann Pharmacother 39:1353–1357
    • View reference on PubMed
    • View reference on publisher's website
  14. Bernuau J, Rueff B, Benhamou JP (1986) Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 6:97–106
    • View reference on PubMed
    • View reference on publisher's website
  15. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Acute kidney injury network (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31
    • View reference on PubMed
    • View reference on publisher's website
  16. Bernard A, Lauwerys RR (1983) Continuous flow system for the automation of latex immunoassay. Clin Chem 29:1007–1011
    • View reference on PubMed
  17. Lauwerys R, Hoet P (2001) Industrial chemical exposure: guidelines for biological monitoring. 3rd edn. Lewis Publ, Boca Raton
  18. Finn W, Porter G (2008) Urinary biomarkers and nephrotoxicity. In: De Broe M, Porter G (eds) Clinical nephrotoxins. Renal injury from drugs and chemicals, 3rd edn. Springer, New York, pp 91–130
  19. Bernard A (2004) Renal dysfunction induced by cadmium: biomarkers of critical effects. Biometals 17:519–523
    • View reference on PubMed
    • View reference on publisher's website
  20. Nordberg GF, Kido T, Roels H (2008) Cadmium-induced renal effects. In: De Broe M, Porter G (eds) Clinical nephrotoxins. Renal injury from drugs and chemicals, 3rd edn. Springer, New York, pp 785–810
  21. EL-Safty IAM, Afifi AMH, Shouman AE, EL-Sady AKR (2004) Effects of smoking and lead exposure on proximal tubular integrity among egyptian industrial workers. Arch Med Res 35:59–65
    • View reference on PubMed
    • View reference on publisher's website
  22. Melichar B, Jandik P, Malir F, Vavrova J, Bures J, Mergancova J, Voboril Z (1995) Association between renal tubular cell dysfunction and increased urinary zinc excretion in cancer patients. Scand J Clin Lab Invest 55:149–152
    • View reference on PubMed
    • View reference on publisher's website
  23. Yuzbasiyan-Gurkan VA, Brewer GJ, Vander AJ, Guenther MJ, Prasad AS (1989) Net renal tubular reabsorption of zinc in healthy man and impaired handling in sickle cell anemia. Am J Hematol 31:87–90
    • View reference on PubMed
    • View reference on publisher's website
  24. Dorian C, Gattone VH, Klaassen CD (1995) Discrepancy between the nephrotoxic potencies of cadmium-metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules. Toxicol Appl Pharmacol 130:161–168
    • View reference on PubMed
    • View reference on publisher's website
  25. Vestergaard P, Shaikh ZA (1994) The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden. Toxicol Appl Pharmacol 126:240–247
    • View reference on PubMed
    • View reference on publisher's website
  26. Liu J, Habeebu SS, Liu Y, Klaassen CD (1998) Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats. Toxicol Appl Pharmacol 153:48–58
    • View reference on PubMed
    • View reference on publisher's website
  27. Jarup L, Berglund M, Elinder CG, Nordberg G, Vahter M (1998) Health effects of cadmium exposure—a review of the literature and a risk estimate. Scand J Work Environ Health 24[Suppl]1:1–51
  28. Bem EM, Piotrowski JK, Sobczak-Kozlowska M, Dmuchowski C (1988) Cadmium, zinc, copper and metallothionein levels in human liver. Int Arch Occup Environ Health 60:413–417
    • View reference on PubMed
    • View reference on publisher's website
  29. Orlowski C, Piotrowski JK (1998) Metal composition of human hepatic and renal metallothionein. Biol Trace Elem Res 65:133–141
    • View reference on PubMed
    • View reference on publisher's website
  30. Dudley RE, Gammal LM, Klaassen CD (1985) Cadmium-induced hepatic and renal injury in chronically exposed rats: likely role of hepatic cadmium-metallothionein in nephrotoxicity. Toxicol Appl Pharmacol 77:414–426
    • View reference on PubMed
    • View reference on publisher's website
  31. Nomiyama K, Nomiyama H, Kameda N (1998) Plasma cadmium-metallothionein, a biological exposure index for cadmium-induced renal dysfunction, based on the mechanism of its action. Toxicology 129:157–168
    • View reference on PubMed
    • View reference on publisher's website
  32. Tanaka K (1982) Effects of hepatic disorder on the fate of cadmium in rats. Dev Toxicol Environ Sci 9:237–249
    • View reference on PubMed
  33. Nakajima M, Kobayashi E, Suwazono Y, Uetani M, Oishi M, Inaba T, Kido T, Shaikh ZA, Nogawa K (2005) Excretion of urinary cadmium, copper, and zinc in cadmium-exposed and nonexposed subjects, with special reference to urinary excretion of beta2-microglobulin and metallothionein. Biol Trace Elem Res 108:17–31
    • View reference on PubMed
    • View reference on publisher's website
  34. Ikeda M, Ohashi F, Fukui Y, Takada S, Moriguchi J, Ezaki T (2007) Changes in tubular dysfunction marker levels in parallel with the levels of copper, rather than cadmium, in urine of middle-aged women in non-polluted areas. Int Arch Occup Environ Health 80:171–183
    • View reference on PubMed
    • View reference on publisher's website
  35. Nomiyama K, Nomiyama H, Kameda N, Tsuji A, Sakurai H (1999) Mechanism of hepatorenal syndrome in rats of Long–Evans Cinnamon strain, an animal model of fulminant Wilson’s disease. Toxicology 132:201–214
    • View reference on PubMed
    • View reference on publisher's website
  36. Lin JL, Lin-Tan DT, Chu PH, Chen YC, Huang YL, Ho TC, Lin CY (2009) Cadmium excretion predicting hospital mortality and illness severity of critically ill medical patients. Crit Care Med 37:957–962
    • View reference on PubMed
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement